Table 1. Affinities of PDZ, PTB, FERM, SH2, and ATG8 domains as well as AP2 μ2 for the ACE2 C-terminal peptide as determined by FP.
Peptide sequence | Name | Modification | KD ± SEM (μM) |
ACE2796-805* FITC-QNTDDVQTSF-COO− |
MAGI1 PDZ1 | Unphos. | N.B. |
NHERF3 PDZ1 | 13.9 ± 0.3 | ||
NHERF3 PDZ3 | N.B. | ||
SCRIB PDZ1 | N.B. | ||
SHANK1 PDZ | 8.3 ± 0.2 | ||
SNTA1 PDZ | N.B. | ||
SNX27 PDZ | 4.7 ± 0.3 | ||
TAX1BP3 PDZ | N.B. | ||
ACE2787–798 FITC-SKGENNPGFQNT-NH2 |
DOK1 PTB | Unphos. | N.B. |
FRS2 PTB | N.B. | ||
IRS1 PTB | N.B. | ||
TLN1 PTB | N.B. | ||
TLN2 PTB | N.B. | ||
SNX17 FERM | (100)† | ||
ACE2775–790 FITC-RSGENPYASIDISKGE-NH2 |
AP2 μ2 | Unphos. | (60)† |
pTyr781 | N.B. | ||
pSer783 | (30)† | ||
FYN SH2 | Unphos. | N.B. | |
pTyr781 | 7.0 ± 0.5 | ||
pSer783 | N.B. | ||
NCK1 SH2 | Unphos. | N.B. | |
pTyr781 | N.B. | ||
pSer783 | N.B. | ||
LYN SH2 | Unphos. | N.B. | |
pTyr781 | (60) | ||
pSer783 | N.B. | ||
MAP1LC3A ATG8 | Unphos. | N.B. | |
pTyr781 | N.B. | ||
pSer783 | N.B. | ||
MAP1LC3B ATG8 | Unphos. | N.B. | |
pTyr781 | N.B. | ||
pSer783 | N.B. | ||
GABARAP ATG8 | Unphos. | N.B. | |
pTyr781 | N.B. | ||
pSer783 | N.B. | ||
GABARAPL2 ATG8 | Unphos. | N.B. | |
pTyr781 | N.B. | ||
pSer783 | N.B. |
*MBP was tested as a control for binding (N.B.) due to the PDZ domains being MBP-tagged. †Values in brackets indicate estimated affinities due to incomplete saturation curves.